Hepatoprotective effects of chondroitin sulfate and glucosamine sulfate

Background. Long-term use of chondroprotective agents – chondroitin sulfate (CS) and glucosamine sulfate (GS) in the treatment of osteoarthritis puts forward increased requirements for the safety of drugs, primarily in terms of effects on the liver and kidneys.Objective: systematization of data on t...

Full description

Saved in:
Bibliographic Details
Main Authors: I. Yu. Torshin, A. M. Lila, O. A. Gromova
Format: Article
Language:Russian
Published: IRBIS LLC 2022-01-01
Series:Фармакоэкономика
Subjects:
Online Access:https://www.pharmacoeconomics.ru/jour/article/view/630
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849696975231909888
author I. Yu. Torshin
A. M. Lila
O. A. Gromova
author_facet I. Yu. Torshin
A. M. Lila
O. A. Gromova
author_sort I. Yu. Torshin
collection DOAJ
description Background. Long-term use of chondroprotective agents – chondroitin sulfate (CS) and glucosamine sulfate (GS) in the treatment of osteoarthritis puts forward increased requirements for the safety of drugs, primarily in terms of effects on the liver and kidneys.Objective: systematization of data on the effect of chondroprotectors on liver structure and functions.Material and methods. Using the methods of the theory of topological text analysis, an intellectual analysis of 2319 publications on fundamental and clinical studies of the relationship of CS and GS with liver function was carried out. The search was performed by a key query “(chondroitine OR glucosamine) AND (liver OR hepatic OR hepatocy*)” in the PubMed/MEDLINE database.Results. The systematic analysis indicated a pronounced hepatoprotective effect of CS and GS pharmaceutical substances with a high degree of purification from inorganic and organic impurities. By regulating inflammation processes, lymphocyte function, fat and carbohydrate metabolism in the liver, standardized forms of CS and GS have a beneficial effect on fat metabolism, reduce chronic inflammation in the liver, exhibit antitumor and pronounced hepatoprotective effects on various models of liver intoxication.Conclusion. The results of this analysis allow us to assert the high safety of drugs based on pharmaceutical standardized forms of CS and GS in terms of liver function.
format Article
id doaj-art-e83a1aa4d9ee48acbc168374fc4a5bf7
institution DOAJ
issn 2070-4909
2070-4933
language Russian
publishDate 2022-01-01
publisher IRBIS LLC
record_format Article
series Фармакоэкономика
spelling doaj-art-e83a1aa4d9ee48acbc168374fc4a5bf72025-08-20T03:19:19ZrusIRBIS LLCФармакоэкономика2070-49092070-49332022-01-0114453754710.17749/2070-4909/farmakoekonomika.2021.112372Hepatoprotective effects of chondroitin sulfate and glucosamine sulfateI. Yu. Torshin0A. M. Lila1O. A. Gromova2Federal Research Center “Informatics and Management”, Russian Academy of SciencesNasonov Research Institute of RheumatologyFederal Research Center “Informatics and Management”, Russian Academy of SciencesBackground. Long-term use of chondroprotective agents – chondroitin sulfate (CS) and glucosamine sulfate (GS) in the treatment of osteoarthritis puts forward increased requirements for the safety of drugs, primarily in terms of effects on the liver and kidneys.Objective: systematization of data on the effect of chondroprotectors on liver structure and functions.Material and methods. Using the methods of the theory of topological text analysis, an intellectual analysis of 2319 publications on fundamental and clinical studies of the relationship of CS and GS with liver function was carried out. The search was performed by a key query “(chondroitine OR glucosamine) AND (liver OR hepatic OR hepatocy*)” in the PubMed/MEDLINE database.Results. The systematic analysis indicated a pronounced hepatoprotective effect of CS and GS pharmaceutical substances with a high degree of purification from inorganic and organic impurities. By regulating inflammation processes, lymphocyte function, fat and carbohydrate metabolism in the liver, standardized forms of CS and GS have a beneficial effect on fat metabolism, reduce chronic inflammation in the liver, exhibit antitumor and pronounced hepatoprotective effects on various models of liver intoxication.Conclusion. The results of this analysis allow us to assert the high safety of drugs based on pharmaceutical standardized forms of CS and GS in terms of liver function.https://www.pharmacoeconomics.ru/jour/article/view/630hepatoprotectionefficacy and safety of pharmacotherapychondroitin sulfateglucosamine sulfatetopological data analysis
spellingShingle I. Yu. Torshin
A. M. Lila
O. A. Gromova
Hepatoprotective effects of chondroitin sulfate and glucosamine sulfate
Фармакоэкономика
hepatoprotection
efficacy and safety of pharmacotherapy
chondroitin sulfate
glucosamine sulfate
topological data analysis
title Hepatoprotective effects of chondroitin sulfate and glucosamine sulfate
title_full Hepatoprotective effects of chondroitin sulfate and glucosamine sulfate
title_fullStr Hepatoprotective effects of chondroitin sulfate and glucosamine sulfate
title_full_unstemmed Hepatoprotective effects of chondroitin sulfate and glucosamine sulfate
title_short Hepatoprotective effects of chondroitin sulfate and glucosamine sulfate
title_sort hepatoprotective effects of chondroitin sulfate and glucosamine sulfate
topic hepatoprotection
efficacy and safety of pharmacotherapy
chondroitin sulfate
glucosamine sulfate
topological data analysis
url https://www.pharmacoeconomics.ru/jour/article/view/630
work_keys_str_mv AT iyutorshin hepatoprotectiveeffectsofchondroitinsulfateandglucosaminesulfate
AT amlila hepatoprotectiveeffectsofchondroitinsulfateandglucosaminesulfate
AT oagromova hepatoprotectiveeffectsofchondroitinsulfateandglucosaminesulfate